PharmTech spoke with Ian Bilodeau, managing director, Ardena US about how the expanded use of AI has impacted the ...

Remco Munnik, Arcana, details pharma's shift to data-first operations, AI adoption, and robust data stewardship.

In late December 2025, Charles Ross & Son promoted its five-cubic-foot double cone tumbler blender for small- to mid-scale ...

Supply chains are being diversified and regionalized to mitigate global disruptions, with significant investments in US ...

The third and final portion of Bryant’s exclusive video interview with PharmTech ® deals with the processes known as human-in ...

Our data show that global pharma M&A is becoming more selective and strategically targeted. While North America remains the ...

Digital GMP expectations are increasing, driven by Annex 11 and Annex 22, necessitating robust lifecycle management, data ...

Next-generation biologics, such as bispecifics, fusion proteins, and multi-specifics, have multiple functionalities that ...

In an expansion of his written three-part series for PharmTech, Jason Bryant of ArisGlobal explains the interplay between ...

The field of cancer treatment saw a variety of advancements in 2025, from new dedicated centers to approved treatments to ...

FDA has taken steps to embrace AI in 2025, announcing in December that it will be providing agency staff with agentic AI ...

From a global regulatory perspective, Cytokinetics is expanding its footprint rapidly. The drug received approval in China on ...